Tomoya Saeki Selected Research

G Protein-Coupled Inwardly-Rectifying Potassium Channels

7/2022

Involvement of spinal G-protein inwardly rectifying potassium (GIRK) channels in the enhanced antinociceptive effects of the activation of both μ-opioid and cannabinoid CB1 receptors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tomoya Saeki Research Topics

Disease

2	Neoplasms (Cancer) 01/2022 - 12/2021
2	Pain (Aches) 01/2022 - 07/2015
1	Neuralgia (Stump Neuralgia) 07/2022
1	Neoplasm Metastasis (Metastasis) 01/2022
1	Cancer Pain 01/2022
1	Dizziness (Lightheadedness) 12/2021

Drug/Important Bio-Agent (IBA)

4	Opioid Analgesics (Opioids)IBA 07/2022 - 07/2015
2	Opioid Receptors (Opioid Receptor)IBA 07/2022 - 07/2015
1	Cannabinoid Receptors (Cannabinoid Receptor)IBA 07/2022
1	G Protein-Coupled Inwardly-Rectifying Potassium ChannelsIBA 07/2022
1	Morphine (MS Contin)FDA LinkGeneric 07/2022
1	Tapentadol FDA Link 12/2021
1	Analgesics (Analgesic Drugs)IBA 12/2021
1	Narcotic Antagonists (Opioid Antagonists)IBA 07/2015
1	naltrindoleIBA 07/2015
1	Formaldehyde (Formol)FDA Link 07/2015
1	Naloxone (Narcan)FDA LinkGeneric 07/2015
1	pre-prodynorphinIBA 07/2015
1	Pentazocine (Talwin)FDA LinkGeneric 07/2015
1	Messenger RNA (mRNA)IBA 07/2015

Therapy/Procedure

1	Ligation 07/2022
1	Therapeutics 12/2021